Episode

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

Podcast

Few & Far Between: How Biotech Gets Built

Published

Jul 22, 2025

Duration seconds

2693

Processing state

not_requested

Canonical source

https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-57-jim-brown-dvm-president-and-ceo-of-durmuy

Audio

https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2094805/c1e-41o1qi183zdc9drqo-3477xgo4iqz5-9f3doi.mp3

JSON

/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-57-jim-brown-dvm-president-and-ceo-of-durect-corporation

Markdown

/podcast/few-far-between-how-biotech-gets-built-4067896/episode-57-jim-brown-dvm-president-and-ceo-of-durect-corporation.md

Actions

• POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-57-jim-brown-dvm-president-and-ceo-of-durect-corporation/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-57-jim-brown-dvm-president-and-ceo-of-durect-corporation.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

Is the epigenome the "software" of the cell nucleus? Find out in our latest episode of the Biorasi Few & Far Between podcast! Host Chris O'Brien welcomes Jim Brown, President and CEO of DURECT Corporation, for a conversation on the importance of a pharmacoeconomic strategy, developing new treatments for alcohol associated hepatitis, and moving beyond what a single individual can do in clinical research. Tune in today!